Stay updated on Vibegron in Women with Irritable Bowel Syndrome Clinical Trial
Sign up to get notified when there's something new on the Vibegron in Women with Irritable Bowel Syndrome Clinical Trial page.

Latest updates to the Vibegron in Women with Irritable Bowel Syndrome Clinical Trial page
- CheckyesterdayChange DetectedThe footer’s revision indicator changed from v3.7.0 to v3.7.1; the study record is still not displayed.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previous content with an access-denied screen; users can no longer view the trial’s official title, summary, locations, or related details.SummaryDifference18%

- Check43 days agoChange Detected- Revision: v3.6.6 updated from v3.6.5, indicating a refreshed page version. No substantive study data, eligibility criteria, or content were modified.SummaryDifference0.0%

- Check65 days agoChange DetectedFooter revision updated from v3.6.4 to v3.6.5. This indicates a small template or rendering update rather than a change to the study data or its presentation.SummaryDifference0.0%

- Check79 days agoChange DetectedPage revision tag updated from v3.6.3 to v3.6.4, indicating a small platform/template update. This behind-the-scenes change does not modify the study information or how users interact with the page.SummaryDifference0.0%

- Check101 days agoChange DetectedThe page’s revision label updated from v3.6.2 to v3.6.3, indicating a new version of the site tooling. This reflects a newer version of the site rather than a change to the study content.SummaryDifference0.0%

Stay in the know with updates to Vibegron in Women with Irritable Bowel Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vibegron in Women with Irritable Bowel Syndrome Clinical Trial page.